Browse Lab Results > 2006-0290

Site: Ovary

Inclusion Criteria:

• Females
• No Prior History of Any Cancer
• No Report of Bilateral Oophorectomy
• Exclude LMPs and Reported Cancers

Matching Factors:

• Age at Serum Draw (5 years)
• Year of Serum Draw

Match Ratio: 4:1 for general controls, 2:1 for controls who ever had an elevated CA-125, and 2:1 for controls who have a family history of breast or ovarian cancer

Match Technique: Frequency matching only non-cases as controls.

Analytes:

• A Disintegrin and Metalloproteinase With a Thrombospondin Type 1 Motif, Member 13
• AGRP
• Aldehyde Dehydrogenase 1 Family, Member A1
• Alpha-1 Antitrypsin
• Alpha-1-Acid Glycoprotein 1
• Alpha-2-Heremans-Schmid Glycoprotein
• Ankyrin Repeat Domain 63
• Anti-4B7 IgG Autoantibody
• Anti-4B7 IgM Autoantibody
• Anti-ARID1A IgG Autoantibody
• Anti-ARID1A IgM Autoantibody
• Anti-CA-125 IgG Autoantibody
• Anti-CA-125 IgM Autoantibody
• Anti-CK 19 IgG Autoantibody
• Anti-CK 19 IgM Autoantibody
• Anti-Cancer/Testis Antigen 1A IgG Autoantibody
• Anti-Cancer/Testis Antigen 1A IgM Autoantibody
• Anti-HARS IgG Autoantibody
• Anti-HARS IgM Autoantibody
• Anti-HE4 IgG Autoantibody
• Anti-HE4 IgM Autoantibody
• Anti-HRAS IgG Autoantibody
• Anti-HRAS IgM Autoantibody
• Anti-IL-8 IgG Autoantibody
• Anti-IL-8 IgM Autoantibody
• Anti-KRAS IgG Autoantibody
• Anti-KRAS IgM Autoantibody
• Anti-LDHA IgG Autoantibody
• Anti-LDHA IgM Autoantibody
• Anti-OVX1 IgG Autoantibody
• Anti-OVX1 IgM Autoantibody
• Anti-PDGF-BB IgG Autoantibody
• Anti-PDGF-BB IgM Autoantibody
• Anti-SURV IgG Autoantibody
• Anti-SURV IgM Autoantibody
• Anti-T71-2A IgG Autoantibody
• Anti-T71-2A IgM Autoantibody
• Anti-TP53 IgG Autoantibody
• Anti-TP53 IgM Autoantibody
• Anti-UCHL1 IgG Autoantibody
• Anti-UCHL1 IgM Autoantibody
• Anti-VEGF IgG Autoantibody
• Anti-VEGF IgM Autoantibody
• Anti-c-Myc IgG Autoantibody
• Anti-c-Myc IgM Autoantibody
• Anti-p53 IgG Autoantibody
• Anti-p53 IgM Autoantibody
• Apolipoprotein A-I
• Apolipoprotein A-II
• Apolipoprotein B
• Apolipoprotein C-II
• Apolipoprotein C-III
• Apolipoprotein E
• C-Reactive Protein
• Cancer Antigen 125
• Carcinoembryonic antigen
• Chemokine
• Chr7_422_10(012)
• Chromosome X Open Reading Frame 21
• Clusterin
• Collagen, Type I, Alpha 1
• Complement Component 9
• Complement Factor D
• Cytokeratin
• Eotaxin
• Epidermal Growth Factor Receptor
• Fibrinogen
• Fibroblast Activation Protein-alpha
• Follicle Stimulating Hormone
• Galectin-3
• Growth Hormone
• Hemopexin
• Interleukin-2 Receptor 
• Lumican
• Macrophage Migration Inhibitory Factor
• Matrix Metalloproteinase-2
• Matrix Metalloproteinase-3
• Melanoma inhibitory activity
• Melanoma-Associated Antigen C1
• Neural Cell Adhesion Molecule
• Paraoxonase 1
• Platelet-Derived Growth Factor-AA
• Prolactin
• Pulmonary and Activation-Regulated Chemokine
• Retinol-Binding Protein 4
• SCGB1A1
• Soluble FAS
• Soluble FAS Ligand
• Soluble Vascular Cell Adhesion Molecule 1
• Thyroid-Stimulating Hormone
• Tissue Plasminogen Activator Inhibitor-1
• Transferrin
• Transthyretin
• Tumor Protein P53
• Vascular Adhesion Protein
• Vitamin D Binding Protein
• X-Ray Induced P53-dependent #1

Number of Cases: 119

Number of Controls: 952

---